Form 8-K - Current report:
SEC Accession No. 0001193805-25-001357
Filing Date
2025-09-25
Accepted
2025-09-25 07:01:02
Documents
28
Period of Report
2025-09-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e664856_8k-immunic.htm   iXBRL 8-K 27485
2 e664856_ex99-1.htm EX-99.1 38373
3 e664856_ex99-2.htm EX-99.2 9571
7 GRAPHIC image1.jpg GRAPHIC 4723
8 GRAPHIC slide1.jpg GRAPHIC 121480
9 GRAPHIC slide2.jpg GRAPHIC 163097
10 GRAPHIC slide3.jpg GRAPHIC 171979
11 GRAPHIC slide4.jpg GRAPHIC 219113
12 GRAPHIC slide5.jpg GRAPHIC 210165
13 GRAPHIC slide6.jpg GRAPHIC 189267
14 GRAPHIC slide7.jpg GRAPHIC 190245
15 GRAPHIC slide8.jpg GRAPHIC 185946
16 GRAPHIC slide9.jpg GRAPHIC 202676
17 GRAPHIC slide10.jpg GRAPHIC 191609
18 GRAPHIC slide11.jpg GRAPHIC 155087
19 GRAPHIC slide12.jpg GRAPHIC 195615
20 GRAPHIC slide13.jpg GRAPHIC 240781
  Complete submission text file 0001193805-25-001357.txt   3619221

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE imux-20250925.xsd EX-101.SCH 3002
5 XBRL LABEL FILE imux-20250925_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE imux-20250925_pre.xml EX-101.PRE 22350
30 EXTRACTED XBRL INSTANCE DOCUMENT e664856_8k-immunic_htm.xml XML 3785
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36201 | Film No.: 251340217
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)